BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models
Federica Guffanti(Mario Negri Institute for Pharmacological Research), Giovanna Damia(Mario Negri Institute for Pharmacological Research)
Cited by 3